Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis.
Unmasking and provoking severe disease activity in a patient with NMO spectrum disorder.
Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.
Moyamoya disease in a patient with neuromyelitis optica.
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patients.
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study.
Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness).
Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.
The BDNF val(66)met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.
Specialized housing and transportation needs of adults with multiple sclerosis.
Primary Position Upbeat Nystagmus during an Acute Attack of Multiple Sclerosis.
Biomarker time out.
Tamoxifen administration immediately or 24 hours after spinal cord injury improves locomotor recovery and reduces secondary damage in female rats.
A Potential Alternative against Neurodegenerative Diseases: Phytodrugs.
Computerised cognitive training in acquired brain injury: A systematic review of outcomes using the International Classification of Functioning (ICF).
Neuroinflammation: The Devil is in the Details.
Clinical characteristics of intermediate uveitis in adult Turkish patients.
Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.
Spontaneous white matter lesion in brain of stroke-prone renovascular hypertensive rats: a study from MRI, pathology and behavior.
Brain ageing and disorders of the central nervous system: kynurenines and drug metabolism.
Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.
Cesarean section and offspring's risk of multiple sclerosis: a Danish nationwide cohort study.
Silent, invisible and unacknowledged: experiences of young caregivers of single parents diagnosed with multiple sclerosis.
Multiple sclerosis: Daclizumab HYP shows efficacy in patients with relapsing-remitting MS.
Four FCRL3 Gene Polymorphisms (FCRL3_3, _5, _6, _8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study.
Pages
« first
‹ previous
…
551
552
553
554
555
556
557
558
559
…
next ›
last »